Skip to main content

Table 4 Characteristics of published studies of the association between the eNOS genotype (Glu298Asp) and pre-eclampsia included in the meta-analysis

From: Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis

Study-year (Country)

Study design

Matching

Asp/Asp * genotype (%)

Primiparous (%) Cases Controls

Proteinuria threshold

Systolic/Diastolic blood pressure threshold

Main exclusion criteria

Caucasians

Hakli T-2003 (Finland)

Case-control

Age

10.61

100

--

0.3 g/24 h

140/90

• Hypertension

Tempfer CB-2004‡ (Austria)

Case-control

Gestational age and parity

--

--

--

5 g/24 h

160/110

• Cardiac (Hypertension), diabetes mellitus or renal disease

• Multiple pregnancies

• Autoimmune disorders & history of recurrent miscarriage

Oriental

Yoshimura T-2000 (Japan)

Case-control

Age

1.17

68.7

80

0.3 g/L

140/90

• Cardiac, diabetes mellitus or renal disease

• Lupus erythematosus

• Multiple pregnancies

Kobashi G-2001 (Japan)

Case-control

--

0

59.2

57

0.3 g/L

140/90

• Hypertension, diabetes mellitus or renal disease

• Multiple pregnancies

• Amniotic volume abnormalities or fetal anomalies

Watanabe H-2001‡ (Japan)

Case-control

--

3.12

--

--

2 g/24h

160/110

• Hypertension

• Renal disease

Ohta K-2004‡ (Japan)

Case-control

--

0

100

100

2 g/24 h

160/110

• Hypertension, diabetes mellitus, renal disease

• Multiple pregnancies

• Amniotic volume abnormalities or fetal anomalies

Kim YJ (Korea)

Case-control

--

--

21

31

0.3 g/L

140/90

• Hypertension, diabetes mellitus or renal disease

• Multiple pregnancies, recurrent miscarriages, fetal growth retardation or abruption placenta

Asians

Yoshimura T-2003‡ (Bangladesh)

Case-control

Age

3.36

44.6

51.2

≥ 3+ dipstick

160/110

• Hypertension, Diabetes mellitus or renal disease

• Lupus erythematosus

• Multiple pregnancies

Afro-Caribbeans

Hillermann R‡ (South Africa)

Case-control

--

1.19

100

--

0.3 g/L

--/90

• Hypertension, diabetes mellitus, renal disease

Study-year (Country)

Study design

Matching

Asp/Asp * genotype (%)

Primiparous (%) Cases Controls

Proteinuria threshold

Systolic/Diastolic blood pressure threshold

Main exclusion criteria

Mixed population †

Landau R-2004 (United States)

Case-control

--

5.03

55

41

0.3 g/L

140/90

• Hypertension

Yu C. KH-2004 (United Kingdom)

Case-control

--

7.44

56.3

69.3

0.3 g/24 h

140/90

• Cardiac, diabetes mellitus or renal disease

• Lupus erythematosus

• Multiple pregnancies

Serrano NC-2004 (Colombia)

Case-control

--

1.14

100

100

0.3 g/24 h

140/90

• Cardiac (Hypertension), diabetes mellitus or renal disease

• Multiple pregnancies

• Lupus erythematosus

  1. *; Genotype frequency from control subjects. ‡ Studies in which only women with severe pre-eclampsia were included as cases.
  2. †; Landau R included Hispanic and White American women, Yu C.KH included Caucasian, Afro-Caribbean, and Asian women and Serrano N included Hispanic and Afro-Caribbean women.